Martin calls for intervention to speed up release of melanoma drug

The Taoiseach has been called on to ensure that Irish patients can get access to a new breakthrough drug to treat skin cancer.

The Taoiseach has been called on to ensure that Irish patients can get access to a new breakthrough drug to treat skin cancer.

The Fianna Fáil leader Micheál Martin said the drug ipilimumab should be introduced into the public health system.

Enda Kenny said the drug is due for release, but discussions had to take place about the cost of the medicine before that could happen.

The melanoma drug is available in the UK and Holland.

Deputy Martin said the Taoiseach should intervene to ensure Irish patients had access to the medicine.

"Patients have been denied access to this treatment for too long," he said.

"One of the good strengths of this country actually was (that) we were very good at facilitating breakthrough drugs, particularly in oncology and indeed in cardiology."

more courts articles

Football fan given banning order after mocking Munich air disaster Football fan given banning order after mocking Munich air disaster
Man (25) in court charged with murdering his father and attempted murder of mother Man (25) in court charged with murdering his father and attempted murder of mother
Man appears in court charged with false imprisonment of woman in van Man appears in court charged with false imprisonment of woman in van

More in this section

WHO teams up with 500 experts to define transmission of diseases spread 'through the air' WHO teams up with 500 experts to define transmission of diseases spread 'through the air'
Justice Minister's decision not to attend GRA conference 'extremely disappointing'  Justice Minister's decision not to attend GRA conference 'extremely disappointing' 
Hiqa inspection finds pests and overcrowding in asylum seeker accommodation centres Hiqa inspection finds pests and overcrowding in asylum seeker accommodation centres
War_map
Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited